-
COST-EFFECTIVENESS OF ORAL NIRMATRELVIR-RITONAVIR IN PATIENTS AT HIGH RISK FOR PROGRESSION TO SEVERE COVID-19 IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
HOSPITAL COSTS OF TREATING INFANTILE-ONSET SMA PATIENTS WITH HIGH DOSE NUSINERSEN (50/28 MG) VS STANDARD DOSE NUSINERSEN (12/12 MG) IN ITALY
Aug 11, 2026, 17:16 PM -
ASSOCIATIONS BETWEEN BRONCHIECTASIS SYMPTOMS AND CLINICAL OUTCOMES: PROTOCOL FOR A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS FEASIBILITY ASSESSMENT
Aug 11, 2026, 17:16 PM -
SUPPORTING DECISION-GRADE CLINICAL BENCHMARKING FOR PERCUTANEOUS CORONARY INTERVENTION: RE-DEVELOPMENT AND TEMPORAL VALIDATION OF A NATIONAL RISK MODEL FOR POST-PCI MORTALITY
Aug 11, 2026, 17:16 PM -
EARLY ECONOMIC EVALUATION OF BLOOD-BRAIN BARRIER MODULATION ACROSS LUNG CANCER BRAIN METASTASIS TREATMENT PATHWAYS IN THE UK NHS
Aug 11, 2026, 17:16 PM -
EVIDENCE FOR RENAL RECOVERY WITH AVACOPAN IN ANCA-ASSOCIATED VASCULITIS AND POTENTIAL IMPLICATIONS FOR HEALTHCARE RESOURCE UTILIZATION
Aug 11, 2026, 17:16 PM -
ESTABLISHMENT OF THE IMPORTANCE OF AND MEANINGFUL CHANGE IN PHYSICAL ACTIVITY IN PATIENTS WITH CANCER CACHEXIA; A DHT-MEASURABLE CONCEPT
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF ACTISTM HIP SYSTEM AND KINCISETM 2 SYSTEM IN PATIENTS UNDERGOING PRIMARY TOTAL HIP ARTHROPLASTY IN SPAIN...
Aug 11, 2026, 17:16 PM -
CHANGES IN PHYSICAL AND COGNITIVE STATUS FOLLOWING HOSPITALIZATION FOR RESPIRATORY TRACT INFECTIONS IN OLDER ADULTS: A POPULATION-BASED STUDY USING JAPANESE ADMINISTRATIVE DATA
Aug 11, 2026, 17:16 PM -
VIGNETTE-DERIVED HEALTH STATE UTILITIES IN SCANDINAVIAN HTA ASSESSMENTS
Aug 11, 2026, 17:16 PM -
FIT FOR PREVENTION? VACCINES UNDER THE EUROPEAN UNION JOINT CLINICAL ASSESSMENT FRAMEWORK: A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF APIXABAN VERSUS ACENOCOUMAROL FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN ALGERIA
Aug 11, 2026, 17:16 PM -
SEASONAL BURDEN, REGIONAL VARIATION, AND HEALTH-SYSTEM SIGNALS IN IN-HOSPITAL PNEUMONIA MORTALITY
Aug 11, 2026, 17:16 PM -
IS GENERIC SUBSTITUTION A POLICY BLUEPRINT FOR BIOSIMILAR SUBSTITUTION IN COMMUNITY PHARMACY?
Aug 11, 2026, 17:16 PM -
LONG-TERM EFFICACY OF NETAKIMAB IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS (R-AXSPA): SIMULATED TREATMENT COMPARISONS RESULTS
Aug 11, 2026, 17:16 PM -
INCLUSION OF ML-NMR RESULTS IN PROBABILISTIC SENSITIVITY ANALYSIS: BALANCING BIAS AND COMPUTATIONAL COST
Aug 11, 2026, 17:16 PM -
DOES PRIMARY ENDPOINT TYPE INFLUENCE REGULATORY AND HTA OUTCOMES FOR EMA APPROVED ONCOLOGY MEDICINES IN ITALY?
Aug 11, 2026, 17:16 PM -
REACTOGENICITY OF NUVAXOVID AND OTHER COMMERCIALIZED COVID-19 VACCINES: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
Aug 11, 2026, 17:16 PM -
EVALUATING AUTOMATED DEDUPLICATION: A PERFORMANCE COMPARISON OF EASYSLR AND ENDNOTE IN MULTI-DATABASE SYSTEMATIC LITERATURE REVIEWS
Aug 11, 2026, 17:16 PM -
ASSESSMENT OF DIETARY HABITS AMONG WOMEN DIAGNOSED WITH ENDOMETRIOSIS
Aug 11, 2026, 17:16 PM
